Mark Griffiths
Amministratore Delegato presso Dishman Group
Posizioni attive di Mark Griffiths
Società | Posizione | Inizio | Fine |
---|---|---|---|
Dishman Group | Amministratore Delegato | - | - |
Covam Ltd. | Direttore/Membro del Consiglio | - | - |
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. | Direttore/Membro del Consiglio | - | - |
Dishman Pharma Solutions AG
Dishman Pharma Solutions AG Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Pharma Solutions AG is a Swiss company that manufactures and processes drugs. The company is based in Bubendorf, Switzerland. | Direttore/Membro del Consiglio | - | - |
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The company is based in London, UK. Dishman Europe was founded in 1997. | Direttore/Membro del Consiglio | 10/10/2014 | - |
Storia della carriera di Mark Griffiths
Precedenti posizioni note di Mark Griffiths
Società | Posizione | Inizio | Fine |
---|---|---|---|
CARBOGEN AMCIS AG
CARBOGEN AMCIS AG Pharmaceuticals: MajorHealth Technology CARBOGEN AMCIS AG provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries. It offers services such as process research, process optimization, formulation, supply of pharmaceutical intermediates, active pharmaceutical ingredients manufacturing, project management, and safety. The company was founded in 2006 and is headquartered in Bubendorf, Switzerland. | Amministratore Delegato | - | 01/04/2022 |
DISHMAN CARBOGEN AMCIS LIMITED | Direttore/Membro del Consiglio | 01/08/2014 | 01/04/2022 |
Amministratore Delegato | 01/08/2014 | 07/02/2019 | |
Vendite & Marketing | 07/02/2019 | 01/04/2022 | |
COSAM Developments Ltd. | Fondatore | 01/06/2008 | 01/08/2011 |
Corporate Officer/Principal | 01/06/2008 | 01/08/2011 | |
Carbogen Amcis Ltd.
Carbogen Amcis Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Carbogen Amcis Ltd. develops and commercializes pharmaceutical products. The company is based in Manchester, UK. Carbogen Amcis was founded in 2005. | Direttore/Membro del Consiglio | 25/04/2016 | - |
░░░░░░░░ ░░░░░ ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | - | |
░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | - |
Formazione di Mark Griffiths
University of Bristol | Graduate Degree |
Statistiche
Distribuzione geografica
India | 6 |
Regno Unito | 5 |
Svizzera | 3 |
Posizioni
Director/Board Member | 8 |
Chief Executive Officer | 4 |
Graduate Degree | 1 |
Settori
Health Technology | 9 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
DISHMAN CARBOGEN AMCIS LIMITED | Health Technology |
Aziende private | 10 |
---|---|
CARBOGEN AMCIS AG
CARBOGEN AMCIS AG Pharmaceuticals: MajorHealth Technology CARBOGEN AMCIS AG provides solutions for the development and supply of drug substances as well as drug products to the pharmaceutical and biopharmaceutical industries. It offers services such as process research, process optimization, formulation, supply of pharmaceutical intermediates, active pharmaceutical ingredients manufacturing, project management, and safety. The company was founded in 2006 and is headquartered in Bubendorf, Switzerland. | Health Technology |
Dishman Pharmaceuticals & Chemicals Ltd.
Dishman Pharmaceuticals & Chemicals Ltd. Pharmaceuticals: MajorHealth Technology Dishman Pharmaceuticals & Chemicals Ltd. manufactures and markets drugs, intermediates, fine chemicals and quats. It operates through the following business segments: Contract Research & Manufacturing and Others. The Contract Research & Manufacturing segment develops intermediates and active pharmaceutical ingredients. The others segment trades in bulk drugs, intermediates, quats, specialty chemicals and outsourced goods. The company was founded on June 29, 1983 and is headquartered in Ahmedabad, India. | Health Technology |
Dishman Europe Ltd.
Dishman Europe Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Europe Ltd. is a British company that imports and markets a wide range of chemical products and pharmaceutical ingredients. The company is based in London, UK. Dishman Europe was founded in 1997. | Health Technology |
Dishman Netherlands BV
Dishman Netherlands BV Pharmaceuticals: OtherHealth Technology Part of Adimans Technologies LLP, Dishman Netherlands BV is a Dutch innovative company dedicated to the re-use of critical raw materials. The company successfully developed a market study for the EU funded REECOVER project, focused on the re-use of rare earths from electronic waste and mine tailings. Currently, in the EU funded ICARUS project, Dishman Netherlands is responsible for market studies, IPR management, and the exploitation process of the technologies that are being developed to recycle silicon kerf, graphite, and silica. The company's current trade business activities consist of the trade in triphenyl phosphine oxide (Tppo), which has been one of the company's activities for more than 20 years, with large multinational companies as its main clients. | Health Technology |
Dishman Group | |
Carbogen Amcis (India) Ltd.
Carbogen Amcis (India) Ltd. Pharmaceuticals: MajorHealth Technology Carbogen Amcis (India) Ltd. engages in the manufacture of bulk drugs. It operates through Contract Research and Contract Manufacturing, and Bulk Drugs, Intermediates, Quats, Specialty Chemicals and Traded Goods segments. It offers a portfolio of drug development, and commercialization services to pharmaceutical industry at all stages of new drug development. The company was founded on July 17, 2007 and is headquartered in | Health Technology |
Dishman Pharma Solutions AG
Dishman Pharma Solutions AG Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Dishman Pharma Solutions AG is a Swiss company that manufactures and processes drugs. The company is based in Bubendorf, Switzerland. | Health Technology |
COSAM Developments Ltd. | |
Covam Ltd. | |
Carbogen Amcis Ltd.
Carbogen Amcis Ltd. Pharmaceuticals: MajorHealth Technology Part of Adimans Technologies LLP, Carbogen Amcis Ltd. develops and commercializes pharmaceutical products. The company is based in Manchester, UK. Carbogen Amcis was founded in 2005. | Health Technology |
- Borsa valori
- Insiders
- Mark Griffiths
- Esperienza